?Cancer Research Career Enhancement and Related Activities A strategic goal for the SJCCC is to develop a well-trained, diverse biomedical workforce through research education, training, and career-development activities that promote understanding of the biology and treatment of childhood cancer. Research shows that early intervention strategies, beginning in elementary and middle school, are essential to enhancing the biomedical careers pipeline, especially for students from underrepresented backgrounds. The SJCCC provides the financial support, leadership and institutional infrastructure to support this comprehensive biomedical training pipeline, initiating efforts in elementary school and continuing through the faculty level. Career enhancement activities are led by the Associate Director for Education and Training, Dr. Gerard Zambetti, who also serves as an institutional Vice President and Director of the Academic Programs Office in Biomedical Sciences, allowing a seamless integration of SJCCC and institutional efforts. Dr. Zambetti coordinates the efforts of a qualified group of staff supporting elementary education and outreach, pre- and postdoctoral education and training, and faculty career development activities. He also works closely with the Center Director, Senior Leadership and Program Leaders to develop, evaluate and oversee an extensive portfolio of career enhancement activities across this spectrum. For example, the SJCCC Cancer Education and Outreach Program has worked with thousands of K-5 students and teachers, particularly in underrepresented communities, to inspire pursuit of research careers, and our NCI-funded Pediatric Oncology Education Program has trained more than 1200 students, 23% of whom are underrepresented minorities and 87% of whom have gone on to receive doctoral degrees. Dr. Zambetti and SJCCC members were also instrumental in the development and launch of the St. Jude Graduate School in Biomedical Sciences, a new PhD program focused on translational research that matriculated its first class of 12 students in 2017. The SJCCC also launched the annual Science Scholars of Tomorrow Symposium to provide high school students and teachers insight into cutting-edge pediatric cancer research and the Clinical Shadowing Program for postdoctoral fellows to develop experience in how laboratory research relates to the treatment and care of pediatric cancer patients. In addition, the Center initiated new grant-writing workshops for postdoctoral fellows and faculty to support development of their research careers. Future plans for the next project period include the continued growth and accreditation of the St. Jude Graduate School, the addition of a new Masters program in Global Health, establishment of a certificate-based program for physicians and healthcare providers (St. Jude Global Academy), expansion of our K-12 educational efforts, and a focused initiative to expand NIH/NCI-funded training and educational programs (e.g., R25, T32, K awards) for students and fellows.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA021765-40
Application #
9632003
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-03-01
Budget End
2020-02-29
Support Year
40
Fiscal Year
2019
Total Cost
Indirect Cost
Name
St. Jude Children's Research Hospital
Department
Type
DUNS #
067717892
City
Memphis
State
TN
Country
United States
Zip Code
38105
Dove, Austin P; Manole, Bogdan-Alexandru; Wakefield, Daniel V et al. (2018) Managing local-regional failure in children with high-risk neuroblastoma: A single institution experience. Pediatr Blood Cancer 65:e27408
Kurmasheva, Raushan T; Kurmashev, Dias; Reynolds, C Patrick et al. (2018) Initial testing (stage 1) of M6620 (formerly VX-970), a novel ATR inhibitor, alone and combined with cisplatin and melphalan, by the Pediatric Preclinical Testing Program. Pediatr Blood Cancer 65:
Chamdine, Omar; Elhawary, Ghada Ahmad Saad; Alfaar, Ahmad Samir et al. (2018) The incidence of brainstem primitive neuroectodermal tumors of childhood based on SEER data. Childs Nerv Syst 34:431-439
Heitzer, Andrew M; Ashford, Jason M; Harel, Brian T et al. (2018) Computerized assessment of cognitive impairment among children undergoing radiation therapy for medulloblastoma. J Neurooncol :
Robinson, Katherine M; Yang, Wenjian; Haidar, Cyrine E et al. (2018) Concordance between glucose-6-phosphate dehydrogenase (G6PD) genotype and phenotype and rasburicase use in patients with hematologic malignancies. Pharmacogenomics J :
Teitz, Tal; Fang, Jie; Goktug, Asli N et al. (2018) CDK2 inhibitors as candidate therapeutics for cisplatin- and noise-induced hearing loss. J Exp Med 215:1187-1203
Binder, Randall J; Hatfield, M Jason; Chi, Liying et al. (2018) Facile synthesis of 1,2-dione-containing abietane analogues for the generation of human carboxylesterase inhibitors. Eur J Med Chem 149:79-89
Slayton, William B; Schultz, Kirk R; Kairalla, John A et al. (2018) Dasatinib Plus Intensive Chemotherapy in Children, Adolescents, and Young Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0622. J Clin Oncol 36:2306-2314
Donohoe, Clare; Bosi, Judy K; Sykes, April et al. (2018) Clinical Characteristics of Children and Adolescents Undergoing Hematopoietic Cell Transplantation Who Develop Oral Mucositis. Oncol Nurs Forum 45:457-462
Green, Daniel M; Wang, Mingjuan; Krasin, Matthew J et al. (2018) Serum ALT elevations in survivors of childhood cancer. A report from the St. Jude Lifetime Cohort Study. Hepatology :

Showing the most recent 10 out of 6764 publications